Latest News

Image description

FDA approves Saxenda from Novo Nordisk

Novo Nordisk last week announced that the Food and Drug Administration approved the company's new drug application for Saxenda, a once-daily glucagon-like peptide-1 receptor agonist is used as an adjunct to a reduced-calorie diet and increased physical activity for weight management in adults with obesity or who are overweight.

Image description

Actavis, Adamas approved for Namzaric

Actavis and Adamas Pharmaceuticals last week announced that the Food and Drug Administration approved Namzaric. According to the companies, the drug is used to treat moderate to severe dementia of the Alzheimer's type in patients stablized on memantine hydrochloride and donepezil hydrochloride.

 

Image description

Walgreens Flu Index: Southern states lead in flu activity

The South is experiencing high flu activity as Texas, Mississippi and Louisiana lead the list of top 10 states, according to the latest Walgreens Flu Index, a weekly report developed to provide state- and market-specific information regarding flu activity, and ranking of those experiencing the highest incidences of influenza across the country.